EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Screening of carbapenemase-producing organisms and vancomycin-resistant enterococci by a molecular approach: impact and lessons learned

C Dinh, A Hennebique, M Veloso, N Gonnet, I Pelloux, S David-Tchouda, C Landelle, S Boisset

Journal of Hospital Infection · 2026

DOI: 10.1016/j.jhin.2025.11.044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hospital Infection, 2026. Verfasst von C Dinh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Hygiene Unit, Grenoble Alpes University Hospital, Grenoble, France. Hauptthemen laut MEDLINE: Vancomycin-Resistant Enterococci, Bacterial Proteins, beta-Lactamases, Gram-Positive Bacterial Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BD.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The rapid detection of carriers of emerging extensively drug-resistant bacteria (eXDR), notably carbapenemase-producing organisms (CPOs) and vancomycin-resistant Enterococci, is crucial for controlling their spread and preventing infections. AIM: To evaluate the impact of polymerase chain reaction (PCR) on turnaround time (TAT) for eXDR detection compared to culture methods under routine laboratory conditions, excluding night or weekend analyses. METHODS: A prospective before-and-after study was conducted at a French university hospital. Phase 1 (culture) occurred from February to September 2022, phase 2 (PCR) from September 2022 to March 2023. TAT was defined as the time from sample collection to result delivery to the infection control team and/or physician. Patients aged >18 years meeting specific screening criteria were included. Two PCR kits were utilized: the BD MAX Check-Points CPO kit and the VIASURE Vancomycin resistance Real Time PCR Detection Kit. FINDINGS: A total of 2049 and 1861 patients were included in phases 1 and 2, respectively. Sixteen patients tested eXDR positive for the first time in phase 1, and 25 in phase 2. The median TAT was significantly shorter in phase 2 (22.7 h; 16.0-41.3) compared to phase 1 (43.5 h; 31.9-69.7; P = 0.001). A significant decrease in the median number of contact patients was observed in phase 2 compared to phase 1. The number of total screening test secondary cases and the hospitalization costs were comparable regardless of the eXDR detection method. CONCLUSION: Rapid rectal screening using PCR significantly reduces TAT for results in low-endemic contexts without increasing costs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vancomycin-Resistant EnterococciBacterial Proteinsbeta-LactamasesGram-Positive Bacterial InfectionsMass ScreeningCarrier StateMolecular Diagnostic TechniquesHumansProspective StudiesMiddle AgedAgedMaleFemaleFranceHospitals, UniversityAdultTime FactorsAged, 80 and overPolymerase Chain Reaction

Stichwörter der Autor:innen

Emerging extensively drug-resistant (XDR) bacteriaMedico-economic impactPCR screeningTurnaround time

Substanzen

Bacterial Proteinsbeta-Lactamasescarbapenemase

Autor:innen und Institutionen

  • Hospital Hygiene Unit, Grenoble Alpes University Hospital, Grenoble, France.
  • Bacteriology Laboratory, Grenoble Alpes University Hospital, Grenoble, France; Université Grenoble Alpes, CNRS, UMR 5525, VetAgro Sup, Grenoble INP, CHU Grenoble Alpes, TIMC, Grenoble, France.
  • Data Engineering Unit, Public Health Department, Grenoble Alpes University Hospital, Grenoble, France.
  • CIC 1406 INSERM, Grenoble Alpes University Hospital, Grenoble, France.
  • Bacteriology Laboratory, Grenoble Alpes University Hospital, Grenoble, France.
  • Université Grenoble Alpes, CNRS, UMR 5525, VetAgro Sup, Grenoble INP, CHU Grenoble Alpes, TIMC, Grenoble, France; CIC 1406 INSERM, Grenoble Alpes University Hospital, Grenoble, France; Medical-Economic Evaluation Unit,…

Förderung

  • BD

Zitieren

APA

Dinh, C., Hennebique, A., Veloso, M., Gonnet, N., Pelloux, I., David-Tchouda, S., Landelle, C., & Boisset, S. (2026). Screening of carbapenemase-producing organisms and vancomycin-resistant enterococci by a molecular approach: impact and lessons learned. Journal of Hospital Infection. https://doi.org/10.1016/j.jhin.2025.11.044

Vancouver

Dinh C, Hennebique A, Veloso M, Gonnet N, Pelloux I, David-Tchouda S, et al. Screening of carbapenemase-producing organisms and vancomycin-resistant enterococci by a molecular approach: impact and lessons learned. Journal of Hospital Infection. 2026. doi:10.1016/j.jhin.2025.11.044

BibTeX
@article{Dinh2026,
  author = {Dinh, C and Hennebique, A and Veloso, M and Gonnet, N and Pelloux, I and David-Tchouda, S and Landelle, C and Boisset, S},
  title = {Screening of carbapenemase-producing organisms and vancomycin-resistant enterococci by a molecular approach: impact and lessons learned},
  journal = {Journal of Hospital Infection},
  year = {2026},
  doi = {10.1016/j.jhin.2025.11.044}
}
Kostenlos starten →